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Summary
In human cells, separation of the centrosomes and formation
of a bipolar spindle are essential for correct chromosome
segregation [1]. During interphase, centrosomes are joined
together by the linker proteins C-Nap1 and rootletin [2–4].
At the onset of mitosis, these linker proteins are phosphory-
lated and displaced from centrosomes by the Nek2A kinase,
which is regulated by two Hippo pathway components, Mst2
kinase and the scaffold protein hSav1. The kinesin-5 motor
protein Eg5 promotes centrosome separation in a parallel
pathway to Nek2A [5]. Here, we report that Polo-like kinase
1 (Plk1) functions upstream of the Mst2-Nek2A kinase
module in centrosome disjunction as well as being impor-
tant for Eg5 localization at centrosomes. Plk1 regulates
Mst2-Nek2A-induced centrosome disjunction by phosphor-
ylating Mst2. The absence of Plk1 phosphorylation of Mst2
promotes assembly of Nek2A-PP1g-Mst2 complexes, in
which PP1g counteracts Nek2A kinase activity. In contrast,
Plk1 phosphorylation of Mst2 prevents PP1g binding to
Mst2-Nek2A, allowingNek2A activity to promote centrosome
disjunction. We propose that centrosome disjunction is
regulated by Plk1, providing a well-balanced control
between the counteracting Nek2A and PP1g activities on
the centrosome linker.
Results and Discussion
Plk1 and Aurora A but Not Cdk1 Kinase Activity Are
Essential for Centrosome Disjunction
Two distinct pathways regulate the separation of mammalian
centrosomes in mitosis. The NIMA-related kinase Nek2A,
regulated by the Hippo pathway components Mst2 and
hSav1, triggers the disassembly of the linker proteins C-Nap1
and rootletin by phosphorylation, which is known as disjunc-
tion [2, 3, 6, 7]. Kinesin-5 (human Eg5) motor activity functions
in parallel to Nek2A in centrosome separation [8, 9]. Eg5 is even
able to sever the linker in the absence of the Mst2-hSav1-
Nek2A pathway as long asmotor activity is sufficiently high [5].
Regulation of centrosome disjunction and separation by the
cell-cycle machinery is largely unclear. Cdk1 (cyclin-depen-
dent kinase 1), Plk1, and Aurora A are mitotic kinases that
have been implicated in centrosome disjunction in different
organisms [10–15]. We evaluated the contribution of these
kinases to centrosome disjunction using small-molecule inhib-
itors (Plk1 [BI2536], Aurora A [VX-680], or Cdk1 [RO3306] [11,
16, 17]). Human retinal pigment epithelial (RPE-1) cells ex-
pressing centrin-GFP were treated as outlined in Figure 1A.*Correspondence: e.schiebel@zmbh.uni-heidelberg.deCdk1-inhibited cells remained in mitosis upon MG132
addition, in contrast to a previous study applying complete
inhibition of all Cdks [18]. Inhibition of Cdk1 activity in prome-
taphase did not affect centrosome disjunction compared to
untreated control cells (Figure 1B; Cdk1i versus UT). In
contrast, inhibition of Plk1 or Aurora A (Figure 1B; Plk1i and
AurAi) reduced the distance between the two centrosomes
(Figure 1C) and maintained C-Nap1 and rootletin at centro-
somes (Figures 1D and 1E). Notably, Plk1 inhibition was
more efficient than Aurora A inhibition inmaintaining centroso-
mal C-Nap1 and rootletin, despite the nearly equal centrosome
distance (Figures 1C–1E). The residual amount of linker
proteins in Aurora A-inhibited cells was probably sufficient to
join the two centrosomes together. We could confirm the
role of Plk1 in centrosome disjunction using RPE-1-eGFP-
Plk1as cells [19]. In these cells, the endogenous PLK1 gene
has been replaced by a genetically modified allele (eGFP-
Plk1as), whose ATP-binding pocket can accommodate bulky
purine analogs, which do not inhibit wild-type kinases (see
Figures S1A and S1B available online).
The failure to disassemble the C-Nap1/rootletin linker
suggests that the Mst2-Nek2A centrosome disjunction path-
way is not functional in cells without Plk1 and Aurora A kinase
activity. Therefore, we monitored C-Nap1 phosphorylation by
Nek2A using phosphospecific C-Nap1-Ser2417/2421 anti-
bodies [5]. Phosphorylation of C-Nap1-Ser2417/2421 was
drastically reduced incells thatwere treatedwith thePlk1 inhib-
itor (Figure 1F). Aurora A inhibition was less efficient than Plk1
inhibition in reducing C-Nap1 phosphorylation (Figure 1F).
Thismay reflect the fact that Aurora A kinasemerely stimulates
Plk1 kinase activity by phosphorylating Thr210 in the T loop of
Plk1 [20, 21]. Accordingly, inhibition of both kinases did not
significantly increase the localization of C-Nap1 and rootletin
at centrosomes compared to inhibition of only Plk1 (Figures
S1C–S1E). These data are consistent with the notion that
Aurora A and Plk1 function in a linear pathway where Aurora
A phosphorylates and activates Plk1 [20, 21].
We next askedwhether centrosomes remain joined together
in cells without Plk1 activity because of a persistent C-Nap1
linker. We treated RPE-1-centrin-GFP cells with the Plk1 inhib-
itor BI2536 and depleted the linker protein C-Nap1 by small
interfering RNA (siRNA). In control siRNA-treated cells (Fig-
ure 1G, UT) that were treated with Plk1 inhibitor, centrosome
disjunction failed. In contrast, C-Nap1-depleted cells disjoined
the centrosomes despite Plk1 inhibition (Figures 1G and 1H).
These data suggest a function of Plk1 in dissolving the centro-
somal linker.
Plk1 Is Essential for Directing the Kinesin-5 Motor Eg5
to Centrosomes
Centrosome separation is completely blocked only when both
the Mst2-Nek2A kinase and Eg5-dependent motor pathways
[5] are inactive. Because cells without Plk1 activity arrested
in prometaphase with adjacent centrosomes that were still
connected by the C-Nap1/rootletin linker (Figures S1F and
S1G), we tested whether Plk1 inhibition also affects Eg5
localization. Eg5 is dispersed throughout the cytoplasm in
interphase cells but begins to accumulate at centrosomes in
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Figure 1. Inhibition of Plk1 Prevents Centrosome Disjunction by Affecting Phosphorylation of the Centrosomal Linker Protein C-Nap1 in Early Mitosis
(A) Schematic outline of experiment in (B)–(F). RPE-1-centrin-GFP cells were enriched in G2 by a single thymidine block/release and treated with the indi-
cated inhibitors together with STLC to trap cells in prometaphase. To prevent Cdk1-inhibited cells from exiting mitosis, we added the proteasome inhibitor
MG132.
(B) Cells were fixed and stained with C-Nap1 and rootletin antibodies. Scale bar represents 5 mm.
(C) Distances between the two centrosomes of cells in (B). Results are from three independent experiments; 20 cells were analyzed for each condition.
Data are mean 6 standard error of the mean (SEM).
(D and E) Intensity of C-Nap1 (D) and rootletin (E) signals at centrosomes from cells in (B) was quantified and corrected to centrin-GFP. Results are
from two independent experiments. n > 20 cells were analyzed for each condition (*p < 0.0001, UT/Plk1i; **p < 0.0001, UT/AurAi; +p = 0.0009,
UT/Plk1i; ++p = 0.01, UT/AurAi).
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1147prophase [22]. Eg5 accumulation at centrosomes was dramat-
ically decreased by inhibition of Plk1 (Figures 2A and 2B;
Figure S2A) without significantly affecting the total amount of
Eg5 (Figure 2C). Similar results were obtained with RPE-1-
eGFP- Plk1as cells treated with 3MB-PP1 (Figure S2B). Thus,
we concluded that Plk1 is required for the targeting of Eg5 to
centrosomes.
In human cells, it is unclear how Eg5 is targeted to spindle
poles. We found no evidence for involvement of Cdk1 in this
process (Figure S2C). On the other hand, in cells treated with
low concentrations of nocodazole, Eg5 localized to remnants
of microtubules, whereas in cells with completely depolymer-
ized microtubules, Eg5 was dispersed throughout the cyto-
plasm (Figure S2D). This demonstrates the requirement of
intact microtubules for centrosomal Eg5 localization. Plk1 inhi-
bition might cause Eg5 to be trapped on microtubules that
then prevents localization to the poles. Alternatively, because
Plk1 inhibition causes a decrease in microtubule nucleation
capacity of the spindle poles [11], Eg5 localization might be
indirectly affected. Although the molecular mechanism of cen-
trosomal targeting of Eg5 by Plk1 remains elusive, it confirms
the pivotal role of Plk1 for centrosome separation.
Plk1 Functions Upstream of the Mst2-Nek2A Module
The results presented above suggest that Plk1 functions
upstream of C-Nap1 in the Mst2-Nek2 centrosome disjunction
pathway. We next tested on which level Plk1 regulates the
Mst2-Nek2 kinase module. Mst2 phosphorylates Nek2A on
four residues. When overexpressed, the phosphomimicking
Nek2A-4D (serine-to-aspartate mutant) is able to bypass the
requirement of Mst2 in centrosome disjunction [5]. If Plk1 is
acting upstream of Mst2, then Nek2A-4D should bypass the
need for Plk1 in centrosome disjunction. To test this, we over-
expressed Nek2A-WT, Nek2A-4A (serine-to-alanine mutant),
and Nek2A-4D in cells that were incubated with or without
the Plk1 inhibitor. In the absence of Plk1 inhibition, Nek2A-
WT and Nek2A-4D, but not Nek2A-4A, were able to initiate
premature centrosome separation [5] (Figures 2D and 2E). In
striking contrast, we observed that in cells without Plk1
activity, Nek2A-WToverexpression did not initiate centrosome
separation, whereas the Nek2A-4D mutant was efficient in this
process (Figures 2D and 2E). Consistently, overexpression of
Nek2A-4D allowed hyperphosphorylation of C-Nap1 in Plk1-
inhibited cells (Figure 2F). These data suggest that Plk1 acts
upstream of Mst2-Nek2A module in centrosome disjunction.
Plk1 Inhibits PP1g
Next, we tested whether Plk1 directly regulates Nek2A kinase.
However, Plk1 inhibition did not change localization or activity
of Nek2A (Figures S3A–S3C). An alternative possibility is that
Plk1 inhibition induces upregulation of PP1g phosphatase.
PP1gwas previously found in complex with Nek2A and shown
to counteract the ability of Nek2A to phosphorylate C-Nap1
in vitro [23]. Supporting this hypothesis, depletion of PP1g
by siRNA rescued the centrosome disjunction defect and al-
lowed efficient displacement of C-Nap1 in cells upon Plk1(F) Extracts of untreated (UT) and RO3306 (Cdk1i)+MG132-, BI2536 (Plk1i)-, an
noblotting using C-Nap1 and C-Nap1-Ser2417/2421 antibodies.
(G) RPE-1-centrin-GFP cells were treated with unspecific control (siNSC) or C
antibodies to show C-Nap1 depletion. Numbers indicate the level of C-Nap1 de
cells treated with siC-Nap1 or siNSC siRNA oligos were incubated with the Plk
(H) Distances between the two centrosomes of cells in (G). Results are from
Data are mean 6 SEM.inhibition (Figures 2G–2I). Similar results were obtained with
protein phosphatase inhibitors (Figures S3D and S3E). Hence,
we suggest that the ability of PP1g to counteract Nek2A is in-
hibited by Plk1. Different isoforms of PP1 (PP1a and PP1g)
have been proposed to antagonize Nek2A [23, 24]. Although
we cannot rule out a possible additive regulation of PP1a on
Nek2A, we did not observe changes in PP1a levels when we
depleted PP1g (data not shown), suggesting that PP1g is the
major PP1 isoform that counteracts Nek2A.
Plk1 Selectively Binds and Phosphorylates Mst2
To understand how Plk1 regulates Mst2-hSav1-Nek2A via
PP1g, we performed in vitro kinase assays using recombinant
proteins (Figure S3F). We found that among all of the proteins
tested, Plk1 only phosphorylated Mst2 (Figure 3A). In addition,
in vitro binding assays using recombinant proteins revealed
that Plk1 bound directly to Mst2, but not to hSav1 or Nek2A
(Figure 3B). This specific binding was also observed in immu-
noprecipitation experiments (Figure 3C; Figures S3G and
S3H). Thus, Plk1 interacts with and phosphorylates Mst2.
Using mass spectrometry analysis of Mst2-KD incubated
with recombinant Plk1 in the presence of ATP, we determined
three sites that corresponded to the consensus sequence
of Plk1, all of which were recently identified by in vivo phos-
phoproteome analyses [25–27] (Figure 3D).
Plk1 Regulates Binding of PP1g to Nek2A via Mst2
Phosphorylation
To analyze the functional significance of Mst2 phosphorylation
by Plk1, we generated nonphosphorylatable Mst2S15A,S18A,S316A
(Mst2-3A) and the corresponding phosphomimicking
Mst2S15D,S18D,S316D (Mst2-3D) mutants. We then investigated
the formation of complexes between Mst2, Nek2A, and PP1g.
We cotransfected cells with Mst2, Mst2-3A, or Mst2-3D
together with Nek2A-WT-GFP; immunoprecipitated Nek2A-
GFP; and analyzed bound endogenous PP1g. Additionally, in
one set of HA-Mst2-WT-transfected cells, we inhibited Plk1
with BI2536. Interestingly, when cells either were treated with
Plk1 inhibitor or expressedMst2-3A, we observed a consistent
increase in PP1g andMst2 binding to Nek2A compared to cells
expressing Mst2 or Mst2-3D (Figure 4A). This finding suggests
that lack of Plk1 phosphorylation on Mst2 increases complex
formation between Mst2, Nek2A, and PP1g.
We confirmed the regulation of complex formation between
Nek2A and PP1g by Plk1 with an in vitro binding experiment.
We failed to identify interaction between Mst2 and PP1g,
whereas a strong interaction was observed between Nek2A
and PP1g (Figure S4A) [23]. Next, we asked whether Mst2
regulates the Nek2A-PP1g interaction. Recombinant His-
tagged Mst2-KD kinase that was in part phosphorylated by
endogenous Plk1 was purified from insect cells. To obtain
defined phosphorylated and nonphosphorylated conditions,
we dephosphorylated Mst2-KD with l-phosphatase (Fig-
ure 4B, lane 4) or preincubated Mst2-KD with WT Plk1 (Fig-
ure 4B, lane 6) to hyperphosphorylate the protein. We incu-
bated GST-PP1g-coupled beads together with His-taggedd VX-680 (AurAi)-treated RPE-1-centrin-GFP cells were analyzed by immu-
-Nap1 siRNA oligos (siC-Nap1). Top: fixed cells were stained with C-Nap1
pletion in interphase cells. Data are the average of 20 cells 6 SEM. Bottom:
1 inhibitor BI2536 (Plk1i). Scale bar represents 5 mm.
two independent experiments; 20 cells were analyzed for each condition.
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Figure 2. Plk1 Functions Upstream of the Eg5 and the Mst2-Nek2A Kinase Pathways
(A) RPE-1-centrin-GFP cells were arrested in prometaphase with BI2536 (Plk1i) or kept untreated (UT). Cells were fixed and stained with Eg5 and g-tubulin
antibodies. Right: line scans of g-tubulin (green) and Eg5 signals (orange) along the line shown in the g-tubulin images. Scale bar represents 5 mm.
(B) Centrosomal association of Eg5 was quantified and corrected for corresponding centrin-GFP signals from cells in (A). Results are from two independent
experiments; n > 20 cells were analyzed for each condition (p < 0.0001, UT/Plk1i).
(C) Extracts of cells treated as in (A) were analyzed by immunoblotting.
(D) Myc-tagged Nek2A (-WT, -4A, or -4D) constructs were transfected into U2OS cells, and cells were treated with (Plk1i) or without (UT) Plk1 inhibitor.
Cells were stained with myc and g-tubulin antibodies. Arrows highlight centrosomes. Scale bar represents 10 mm.
(E) Distances between the two centrosomes of cells in (D). Centrosome distance > 2 mm was counted as separated. Results are from three independent
experiments; n > 20 cells were analyzed for each condition. Data are mean 6 SEM.
(F) Extracts of cells treated as in (D) were analyzed by immunoblotting.
(G) RPE-1-centrin-GFP cells were treated with siRNA oligos against PP1g, synchronized in prometaphase, and treated with BI2536. Fixed cells were stained
with C-Nap1 antibodies. Scale bar represents 5 mm.
(H) Centrosomal association of C-Nap1 of cells in (G) was quantified and corrected for centrin-GFP. Results are from two independent experiments;
n > 20 cells were analyzed for each condition (p = 0.0002, NSC/PP1g).
(I) Extracts of cells treated as in (G) were analyzed by immunoblotting.
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1148Nek2A-KD in the presence (Figure 4B, lanes 3–7) and absence
(Figure 4B, lane 2) of His-Mst2-KD and determined the amount
of bound versus unbound His-tagged proteins on the GST-
PP1g-coupled beads. In agreement with the immunoprecipita-
tion experiment (Figure 4A), we observed a strong increase in
Nek2A-KD binding to PP1gwhen Mst2-KD was dephosphory-
lated (Figure 4B, compare lanes 4 and 6). Taking these data
together, we propose that phosphorylation of Mst2 by Plk1
regulates Mst2-PP1g-Nek2A complex formation.
Counteracting Activities of Nek2 and PP1g
Regulate C-Nap1 Phosphorylation
From the experiments described above, three scenarios were
plausible. PP1g in the Mst2-PP1g-Nek2A complex couldcounteract phosphorylation of either Mst2 by Plk1 or Nek2A
by Mst2. Alternatively, PP1g might reduce phosphorylation
of the linker protein C-Nap1 by competing with Nek2A. In order
to test the first two possibilities, we established an in vitro
system where we could study Mst2 phosphorylation and
activity. We preincubated Mst2-WT with either Plk1-KD or
Plk1-WT in the presence of ATP and then used Nek2A-KD or
Nek2A-KD-PP1g as substrates together with [g-32P]ATP.
As reported [28], Mst2 showed autophosphorylation, and
the presence of Plk1 further increased the incorporation of
[g-32P]ATP into Mst2 (Figure 4C, lanes 3, 4, 7, and 8). The level
of Mst2 phosphorylation was unaffected by the presence
of PP1g, suggesting that Mst2 is not a substrate of the phos-
phatase. Because Plk1 only phosphorylated Mst2 in these
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Figure 3. Plk1 Selectively Phosphorylates Mst2 Kinase
(A) Recombinant proteins were incubated with wild-type (WT) or kinase-dead (KD) versions of Plk1 in the presence of [g-32P]ATP. Proteins were separated
by SDS-PAGE and analyzed by Safe Stain and autoradiography.
(B) Purified recombinant GST or GST-Plk1 was incubated with recombinant His-tagged Mst2-KD, hSav1, or Nek2A-KD. GST-tagged proteins were precip-
itated with glutathione Sepharose beads, and bound proteins were analyzed by immunoblotting.
(C) HA-Mst2 together with GFP or GFP-Plk1 was coexpressed in HEK293 cells. GFP-tagged proteins were immunoprecipitated with GFP-binder protein
(GBP)-coupled NHS-activated Sepharose beads. Coimmunoprecipitation of HA-tagged Mst2 was determined by immunoblotting.
(D) Plk1 phosphorylation sites on Mst2 identified by liquid chromatography-tandem mass spectrometry analysis.
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1149reactions (Figure S4B), Nek2A-KD phosphorylation is a reflec-
tion of Mst2 activity. Importantly, Nek2A phosphorylation was
not reduced by the addition of PP1g (Figure 4C, lanes 2, 4, 6,
and 8), suggesting that PP1g does not act on Nek2A. In
summary, PP1g in the Mst1-PP1g-Nek2A complex regulates
neither Mst2 nor Nek2A but instead may constantly dephos-
phorylate substrates of Nek2A.
To test this possibility, we followedC-Nap1 phosphorylation.
For this experiment, we cotransfected cells with WT-Nek2A-
GFPandMst2,Mst2-3A, orMst2-3D.Nek2A-GFPwas immuno-
precipitated, supplementedwith recombinant activeor inactive
PP1g to a concentration that reflected the situation in cells, and
incubated with recombinant C-Nap1-CTD (C-terminal domain)
in the presence of ATP. Finally, phosphorylation of C-Nap1-
CTD was monitored with phosphospecific C-Nap1 antibodies
[5]. Prior inhibition of PP1g with CalA (after immunoprecipita-
tion) effectively prevented dephosphorylation of C-Nap1 (Fig-
ure 4D, lanes 3 and 4). When active but not inactive PP1g was
added to Mst2-WT/Nek2A, C-Nap1 was efficiently dephos-
phorylated (Figure 4D, lanes 1 and 2). Similar results were
obtained with Mst2-3A/Nek2A (Figure 4D, lanes 5 and 6). In
contrast, PP1g did not efficiently dephosphorylate C-Nap1 in
presence of the phosphomimicking Mst2-3D (Figure 4D, lane
8). This indicates that the phosphorylation state of Mst2
controls the balance between Nek2A and PP1g to phosphory-
late C-Nap1. Together, our results support a model in whichPlk1 selectively phosphorylates Mst2. This decreases the
formation of Mst2-PP1g-Nek2A complexes and thereby
promotes C-Nap1 phosphorylation by Nek2A.
Duplicated centrosomes need to be separated at the G2/M
transition in order to form a bipolar spindle in human cells. It
has been reported that upon Plk1 inhibition, cells arrest in
prometaphase with two adjacent centrosomes [11]. Data pre-
sented here now reveal that Plk1 is crucial for Eg5 targeting to
centrosomes at the time of nuclear envelope breakdown.
Additionally, Plk1 selectively phosphorylates Mst2 and pro-
vides control of C-Nap1 phosphorylation through regulating
the counteracting activities of Nek2A and PP1g. Thus, centro-
some disjunction is regulated by Plk1 by providing a balanced
control between the counteracting Nek2A and PP1g activities
on C-Nap1. It will be interesting to see whether Plk1 also regu-
lates the function ofMst2 in the Hippo growth control pathway.Experimental Procedures
Cell Lines and Treatments
For thymidine block and release experiments, cells were incubated in
2.5 mM thymidine-containing medium for 24 hr and released in fresh
medium without thymidine for 6 hr. For inhibition of Eg5 motor activity,
S-trityl-L-cysteine (STLC) was used at a concentration of 5 mM. To inhibit
mitotic kinases, we used BI2536 at 100 nM (unless indicated otherwise),
3MB-PP1 at 10 mM, RO3306 at 5 mM, and VX-680 at 1 mM. For inhibition of
phosphatases, calyculin A was used at 50 ng/ml and okadaic acid at 1 nM.
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Figure 4. Plk1 Phosphorylation of Mst2 Disrupts Formation of the Nek2A-PP1g Complex
(A) HA-Mst2 variants together with GFP-Nek2A were coexpressed in HEK293 cells. Cells were kept with or without BI2536 for 2 hr. GFP-tagged proteins
were immunoprecipitated with GBP beads. Coimmunoprecipitation of HA-Mst2 and endogenous PP1g was determined by immunoblotting. GAPDH
was used as control for IP specificity. Bottom panel: bound PP1g was quantified, corrected for corresponding GFP-IP signals, and normalized to WT.
Data are mean 6 SEM.
(B) Equimolar amounts of recombinant Mst2-KD from insect cells were dephosphorylated by l-phosphatase (lane 4), incubated with l-phosphatase in the
presence of l-phosphatase inhibitors (lane 3), incubated with Plk1-WT (lane 6) or Plk1-KD (lane 5) in the presence of ATP, or kept untreated (lane 7). Mst2
proteins were then mixed with recombinant Nek2A-KD and PP1g-coupled GST Sepharose. After washing, bound and unbound fractions of Mst2-KD and
Nek2A-KD were analyzed by immunoblotting. Bottom: ratios of bound to unbound fractions of Nek2A were determined. Averages from three independent
experiments are shown. Data are mean 6 SEM.
(C) Recombinant Mst2-WT kinase was preincubated with Plk1-WT or Plk1-KD in the presence of ATP. [g-32P]ATP was added, and Mst2 was used as kinase
for in vitro kinase assays with Nek2A-KD or Nek2A-KD+PP1g as substrates. The reactions were stopped after 5 and 20 min. Samples were analyzed by
SDS-PAGE and autoradiography.
(D) HA-Mst2 constructs and GFP-Nek2A were coexpressed in HEK293 cells. GFP-tagged proteins were immunoprecipitated with GBP Sepharose beads.
Immunoprecipitated samples were incubated with either active or inhibited PP1g (+CalA) together with recombinant C-Nap1-CTD as a substrate.
Phosphorylation of C-Nap1 was analyzed using phosphospecific C-Nap1-Ser2417/2421 antibodies.
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Imaging was performed at 25C on a DeltaVision RT system (Applied Preci-
sion) with an Olympus IX71 microscope equipped with FITC, TRITC, and
Cy5 filters (Chroma Technology); Plan Apo 1003 NA 1.4 and 603 NA 1.4
oil-immersion objectives (Olympus); a CoolSNAP HQ camera (Photomet-
rics); a temperature controller (Precision Control); and Softworx software
(Applied Precision).
Protein Methods
Protein purification, in vitro binding experiments, and immunoprecipitation
experiments were carried out as described elsewhere [5]. For details, see
Supplemental Experimental Procedures.Supplemental Information
Supplemental Information includes four figures and Supplemental
Experimental Procedures and can be found with this article online at
doi:10.1016/j.cub.2011.05.047.
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